Calquence earns breakthrough designation for CLL monotherapyAugust 27, 2019Leukemia, Myelodysplasia, Transplantation
Combo produces responses in triple-class refractory myelomaAugust 21, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Zanubrutinib may be poised to challenge ibrutinib for CLLAugust 15, 2019Leukemia, Myelodysplasia, Transplantation
Ibrutinib/rituximab effective, safe as frontline treatment for older patients with MCLAugust 12, 2019Lymphoma & Plasma Cell Disorders
ICYMI: Ibrutinib/rituximab combo improves CLL survivalJuly 31, 2019Leukemia, Myelodysplasia, Transplantation
Timing, volume of transfusion may not matter in children with severe anemiaJuly 31, 2019AnemiaBlood BankingPediatrics
RNA interference drug fitusiran looks effective in both hemophilia A and BJuly 29, 2019Bleeding Disorders
Early phase trial shows durable responses to gene therapy for hemophilia AJuly 29, 2019Bleeding Disorders
Lymphoma risk prompts FDA recall of Allergan’s textured breast implantsJuly 24, 2019Lymphoma & Plasma Cell Disorders
BTK mutations linked to CLL progression on ibrutinibJuly 24, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
